Biotech ETFs Surge After Eli Lilly Buys Out Loxo Oncology

Biotechnology stocks and sector-related ETFs were among the best performers Monday after Eli Lilly (NYSE: LLY) said it will acquire Loxo Oncology Inc. (NasdaqGS: LOXO) for $8 billion. Among the best performers on Monday, the ALPS Medical Breakthroughs ETF (NYSEArca: SBIO) jumped 8.2%, testing its...